Romosozumab Tops Teriparatide in Phase 3 Osteoporosis Study
05.04.16
Bente Langdahl, MD, PhD, professor at the department of endocrinology and internal medicine at Aarhus University Hospital, Denmark, presented at the ENDO16 annual metting results from a promising new drug trial on osteoporosis.
Read more in an article on Medscape.com